STAAR Surgical (STAA)
NASDAQ: STAA
· Real-Time Price · USD
19.04
0.70 (3.82%)
At close: May 02, 2025, 3:59 PM
19.03
-0.05%
After-hours: May 02, 2025, 04:42 PM EDT
STAAR Surgical Revenue Breakdown
| Period Ending | Dec 27, 2024 | Sep 27, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 | Oct 3, 2014 | Jul 4, 2014 | Apr 4, 2014 | Jan 3, 2014 | Sep 27, 2013 | Jun 28, 2013 | Dec 28, 2012 | Sep 28, 2012 | Jun 29, 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Other Surgical Products Revenue | 1.15M | 89.1M | 205K | 1.85M | -540K | -846K | 70.63M | 61.16M | 71.95M | 77.92M | 58.67M | 54.15M | 59.23M | 46.5M | 39.85M | 41.49M | 30.73M | 29.34M | 33.29M | 33.81M | 34.43M | 27.79M | 26.42M | 27.29M | 21.16M | 18.63M | 18.11M | 16.32M | 15.27M | 15.72M | 14.8M | 15.41M | 13.18M | 14.14M | 12.91M | 12.24M | 12.26M | 8.99M | 10.64M | 12.17M | 12.24M | 22.14M | 10.72M | 11.26M | 19.2M | 9.11M | 6.77M |
| Other Surgical Products Revenue Growth | -98.71% | +43363.90% | -88.91% | -442.41% | -36.17% | -101.20% | +15.47% | -15.00% | -7.66% | +32.80% | +8.35% | -8.58% | +27.38% | +16.70% | -3.97% | +35.03% | +4.73% | -11.86% | -1.56% | -1.79% | +23.92% | +5.18% | -3.20% | +28.99% | +13.59% | +2.85% | +10.99% | +6.85% | -2.87% | +6.22% | -3.94% | +16.90% | -6.82% | +9.59% | +5.48% | -0.16% | +36.26% | -15.47% | -12.59% | -0.56% | -44.72% | +106.45% | -4.76% | -41.33% | +110.68% | +34.50% | n/a |
| Implantable Collamer Lenses Revenue | 146.29M | n/a | 77.15M | 319.43M | 81.07M | 93.11M | 1.43M | 884K | 1.9M | 632K | 1.62M | 1.67M | 58K | 526K | 2.46M | 2.26M | 1.91M | 1.85M | 1.89M | 1.15M | 1.36M | 780K | 1.53M | 2.43M | 1.88M | 1.84M | 1.47M | 1.24M | 473K | 1.49M | 602K | 498K | 1.02M | 1.81M | 1.45M | 1.22M | 1.25M | 2.05M | 1.78M | 1.45M | 1.32M | 1.83M | 1.06M | 1.04M | 1.47M | 703K | 562K |
| Implantable Collamer Lenses Revenue Growth | n/a | n/a | -75.85% | +294.02% | -12.93% | +6425.02% | +61.43% | -53.52% | +200.95% | -61.06% | -3.05% | +2786.21% | -88.97% | -78.60% | +8.62% | +18.79% | +2.81% | -1.91% | +64.69% | -15.54% | +74.10% | -48.95% | -37.04% | +29.30% | +1.90% | +25.22% | +18.44% | +162.58% | -68.32% | +148.01% | +20.88% | -51.27% | -43.47% | +24.43% | +19.39% | -2.25% | -39.18% | +14.68% | +23.27% | +9.37% | -27.85% | +73.28% | +1.83% | -29.11% | +108.68% | +25.09% | n/a |
Revenue by Geography
| Period Ending | Dec 28, 2018 | Dec 29, 2017 | Dec 30, 2016 | Jan 1, 2016 | Jan 2, 2015 | Jan 3, 2014 | Dec 28, 2012 |
|---|---|---|---|---|---|---|---|
| China Revenue | 46.07M | 23.88M | 16.02M | 12.57M | 9.37M | 20.47M | 19.55M |
| China Revenue Growth | +92.91% | +49.08% | +27.43% | +34.16% | -54.23% | +4.73% | n/a |
| Japan Revenue | 23.15M | 17.42M | 17.33M | 16.98M | 19.11M | n/a | n/a |
| Japan Revenue Growth | +32.87% | +0.55% | +2.04% | -11.12% | n/a | n/a | n/a |
| Other Countries Revenue | 47.42M | 35.87M | 31.77M | 22.99M | 19.57M | n/a | n/a |
| Other Countries Revenue Growth | +32.19% | +12.90% | +38.20% | +17.45% | n/a | n/a | n/a |
| United States Revenue | 7.32M | 7.89M | 9.86M | 10.9M | 11.12M | n/a | n/a |
| United States Revenue Growth | -7.32% | -19.93% | -9.58% | -1.92% | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 27, 2024 | Sep 27, 2024 | Jun 28, 2024 | Mar 29, 2024 | Dec 29, 2023 | Sep 29, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 30, 2022 | Sep 30, 2022 | Jul 1, 2022 | Apr 1, 2022 | Dec 31, 2021 | Oct 1, 2021 | Jul 2, 2021 | Apr 2, 2021 | Jan 1, 2021 | Oct 2, 2020 | Jul 3, 2020 | Apr 3, 2020 | Jan 3, 2020 | Sep 27, 2019 | Jun 28, 2019 | Mar 29, 2019 | Dec 28, 2018 | Sep 28, 2018 | Jun 29, 2018 | Mar 30, 2018 | Dec 29, 2017 | Sep 29, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 30, 2016 | Sep 30, 2016 | Jul 1, 2016 | Apr 1, 2016 | Jan 1, 2016 | Oct 2, 2015 | Jul 3, 2015 | Apr 3, 2015 | Jan 2, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 59.56K | 48.31M | 52.46M | 49.94M | 39.45M | 45.87M | 50.37M | 44.45M | 39.03M | 37.14M | 38.22M | 29.21M | 28.54M | 29.19M | 30.29M | 23.41M | 21.27M | 21.24M | 18.17M | 19M | 19.07M | 19.56M | 19.19M | 16.98M | 16.1M | 16.71M | 16.86M | 13.59M | 13.45M | 11.38M | 12.08M | 11.89M | 10.35M | 12.13M | 12.11M | 16.14M | 10.77M | 11.14M | 10.57M | 10.78M | 9.87M |
| Selling, General, and Administrative Revenue Growth | -99.88% | -7.91% | +5.05% | +26.57% | -13.99% | -8.94% | +13.32% | +13.89% | +5.09% | -2.81% | +30.83% | +2.36% | -2.25% | -3.63% | +29.39% | +10.10% | +0.13% | +16.86% | -4.33% | -0.40% | -2.49% | +1.93% | +13.02% | +5.47% | -3.63% | -0.88% | +24.03% | +1.05% | +18.20% | -5.84% | +1.62% | +14.91% | -14.74% | +0.21% | -24.98% | +49.90% | -3.32% | +5.38% | -1.98% | +9.26% | n/a |
| Research and Development Revenue | 12.04K | 14.5M | 14.05M | 13.38M | 10.87M | 11.47M | 11.76M | 10.31M | 9.79M | 9.62M | 8.64M | 7.94M | 9.07M | 8.27M | 8.26M | 8.26M | 8.96M | 8.75M | 7.31M | 6.9M | 7.41M | 6.16M | 6.1M | 5.63M | 5.71M | 5.57M | 5.35M | 5.04M | 5.19M | 4.43M | 4.71M | 4.78M | 4.28M | 4.45M | 4.66M | 6.91M | 3.96M | 3.68M | 3.54M | 3.58M | 3.25M |
| Research and Development Revenue Growth | -99.92% | +3.15% | +5.04% | +23.14% | -5.27% | -2.42% | +14.02% | +5.31% | +1.81% | +11.35% | +8.75% | -12.47% | +9.68% | +0.13% | +0.01% | -7.80% | +2.37% | +19.70% | +5.99% | -6.90% | +20.35% | +0.95% | +8.22% | -1.23% | +2.42% | +4.19% | +6.01% | -2.87% | +17.23% | -6.01% | -1.48% | +11.88% | -4.00% | -4.42% | -32.54% | +74.35% | +7.52% | +4.19% | -1.20% | +10.29% | n/a |
| Sales and Marketing Revenue | 26.17K | 26.62M | 28.82M | 26.71M | 22.6M | 26.61M | 32.28M | 26.35M | 24.22M | 23.13M | 24.23M | 17.27M | 17.07M | 18.18M | 18.85M | 13.2M | 11.76M | 12.65M | 10.33M | 11.03M | 11.2M | 12.46M | 11.68M | 10.14M | 9.87M | 10.62M | 10.66M | 7.38M | 7.85M | 6.43M | 7.32M | 6.53M | 6.47M | 7.15M | 7.18M | 7.67M | 5.91M | 6.28M | 5.83M | 5.67M | 5.69M |
| Sales and Marketing Revenue Growth | -99.90% | -7.62% | +7.90% | +18.20% | -15.07% | -17.57% | +22.47% | +8.80% | +4.73% | -4.55% | +40.32% | +1.20% | -6.11% | -3.60% | +42.81% | +12.24% | -7.02% | +22.50% | -6.37% | -1.56% | -10.11% | +6.69% | +15.17% | +2.80% | -7.09% | -0.37% | +44.43% | -5.96% | +22.03% | -12.16% | +12.11% | +0.90% | -9.47% | -0.45% | -6.44% | +29.84% | -5.94% | +7.75% | +2.89% | -0.37% | n/a |